Taiwan
· Delayed Price · Currency is TWD SYN-TECH Chem. & Pharm. Statistics
Total Valuation
SYN-TECH Chem. & Pharm. has a market cap or net worth of TWD 4.33 billion. The enterprise value is 3.75 billion.
| Market Cap | 4.33B |
| Enterprise Value | 3.75B |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Jul 19, 2024 |
Share Statistics
SYN-TECH Chem. & Pharm. has 44.59 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 44.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.11% |
| Float | 23.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.11 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.15, with an EV/FCF ratio of 9.62.
| EV / Earnings | 11.45 |
| EV / Sales | 3.09 |
| EV / EBITDA | 8.15 |
| EV / EBIT | 11.75 |
| EV / FCF | 9.62 |
Financial Position
The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.76 |
| Quick Ratio | 4.75 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.16 |
| Interest Coverage | 88.74 |
Financial Efficiency
Return on equity (ROE) is 13.77% and return on invested capital (ROIC) is 7.63%.
| Return on Equity (ROE) | 13.77% |
| Return on Assets (ROA) | 7.03% |
| Return on Capital (ROIC) | 7.63% |
| Revenue Per Employee | 5.52M |
| Profits Per Employee | 1.49M |
| Employee Count | 220 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +12.87% |
| 50-Day Moving Average | 95.78 |
| 200-Day Moving Average | 90.41 |
| Relative Strength Index (RSI) | 54.04 |
| Average Volume (20 Days) | 95,653 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYN-TECH Chem. & Pharm. had revenue of TWD 1.22 billion and earned 327.48 million in profits.
| Revenue | 1.22B |
| Gross Profit | 452.43M |
| Operating Income | 319.02M |
| Pretax Income | 409.58M |
| Net Income | 327.48M |
| EBITDA | 456.71M |
| EBIT | 319.02M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 641.64 million in cash and 61.42 million in debt, giving a net cash position of 580.22 million or 13.01 per share.
| Cash & Cash Equivalents | 641.64M |
| Total Debt | 61.42M |
| Net Cash | 580.22M |
| Net Cash Per Share | 13.01 |
| Equity (Book Value) | 2.46B |
| Book Value Per Share | n/a |
| Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was 545.70 million and capital expenditures -156.12 million, giving a free cash flow of 389.58 million.
| Operating Cash Flow | 545.70M |
| Capital Expenditures | -156.12M |
| Free Cash Flow | 389.58M |
| FCF Per Share | 8.74 |
Margins
Gross margin is 37.23%, with operating and profit margins of 26.25% and 26.95%.
| Gross Margin | 37.23% |
| Operating Margin | 26.25% |
| Pretax Margin | 33.70% |
| Profit Margin | 26.95% |
| EBITDA Margin | 37.58% |
| EBIT Margin | 26.25% |
| FCF Margin | 32.06% |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.62%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.62% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 47.66% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.62% |
| Earnings Yield | n/a |
| FCF Yield | 9.00% |
Stock Splits
The last stock split was on August 3, 2012. It was a forward split with a ratio of 1.05.
| Last Split Date | Aug 3, 2012 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |